FLORHAM PARK, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI), a clinical-stage biopharmaceutical company developing first-in-class immune-modulating cancer therapies, today announced that the Company will participate in the Immuno-Oncology 360° (IO360°) Conference 2026, held February 10-12, 2026 in Boston, MA. Dr. Lan Huang, Co-Founder, Chairman, and CEO of BeyondSpring, will present on Plinabulin as a differentiated immuno-oncology asset designed to enhance PD-1/PD-LD blockade and ...

Jody and Paul Glaser of Los Altos did what millions of Americans still do every year: they wrote a check for their property taxes and dropped it in a blue USPS mailbox outside the post office. Three months later, a delinquency notice arrived from Santa Clara County. Paul said he knew he'd paid — he'd seen the check clear. So they pulled up the check image online and saw someone else's name where the county tax collector's should have been. "Clearly, the check had been altered, and cashed by somebody els ...

PresentationAs we are a listed company, we strictly follow the disclosure guidelines and can only answer questions within those guidelines. Thank you.Good morning, everyone, and thank you for making time for us on such short notice. Before getting into the details, let me first introduce who are the presenters on the call today. Hein Pretorius, Chairman of the Supervisory Board of InPost; Javier van Engelen, our CFO; and Michael Rouse, our CEO, International. You will notice the absence of the group CEO in ...

Core Insights - XtalPi Inc. has successfully deployed an automated formulation stability testing workstation at BASF, enhancing BASF's R&D capabilities in the chemical industry [1][2][3] - This collaboration marks a significant milestone for XtalPi, showcasing its technological leadership and ability to provide scalable solutions for industry leaders [1][5] Company Overview - XtalPi is a global leader in AI- and robotics-driven R&D platforms, focusing on innovation in pharmaceuticals, petrochemicals, new energy, and advanced materials [1][9] - Founded in 2015 by MIT physicists, XtalPi integrates quantum physics, AI, and robotics to deliver digital and intelligent R&D solutions across various industries [9] Collaboration with BASF - BASF, a major player in the chemical industry, operates in diverse sectors and is committed to green transformation [2][10] - The automated workstation developed by XtalPi addresses BASF's challenges in traditional manual workflows, enhancing efficiency, accuracy, and standardization in testing processes [3][4] Technological Advancements - XtalPi's automated system integrates sample management, analytical testing, and data management into a cohesive workflow, significantly improving operational efficiency [1][3] - The modular and standardized platform allows for rapid deployment and customization, meeting the unique requirements of BASF [4][5] Market Position and Future Outlook - XtalPi's solutions are deployed across various industries, including pharmaceuticals and renewable energy, positioning the company for growth in trillion-dollar markets [7] - The company aims to deepen strategic partnerships with global industry leaders to drive advancements in AI and robotic experimentation [8]

With the crypto market seemingly in free fall these days, it's no surprise that investors are searching for potential safe haven assets. At one time, Bitcoin (CRYPTO: BTC) was supposed to be that safe haven. But it's down more than 25% in 2026, and that hardly sounds safe to me. So what about dollar-pegged stablecoins such as USDC (CRYPTO: USDC)? These stablecoins are specifically designed to retain their value over time. At any time, they can be redeemed 1:1 for U.S. dollars and are fully backed by cash ...

Taking a “set it and forget it” approach to retirement planning works in some areas, such as setting up automatic contributions to retirement savings so you don’t even have to think about it. But in other areas, it’s not the right approach. One of those areas has to do with actively “stress testing” your retirement plan to identify weak points and make adjustments as needed, according to Rob Williams, head of financial planning and wealth management research at Charles Schwab. “Even when your retirement ...

NatWest Group has agreed to purchase UK wealth manager Evelyn Partners from Permira and Warburg Pincus-advised funds in a deal valued at £2.7bn ($3.6bn). The combined business will oversee £127bn in assets under management and administration. Evelyn Partners manages £69bn in client assets. Its operations include financial planning, discretionary investment management, and the consumer platform BestInvest. Permira first invested in Bestinvest in 2014, and Warburg Pincus has been a minority investor sin ...

Ciena (CIEN) shares ended the last trading session 7.2% higher at $271.32. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 12.3% gain over the past four weeks.The increase in share price can be attributed to increased network traffic, demand for bandwidth and the adoption of cloud architecture. Ciena is set to join the S&P 500. The index news is hitting at a time when sentiment on optical networking is already impr ...

If you're contributing money to a 401(k) plan on a regular basis, you're doing your part to set yourself up for a secure retirement. Social Security might only replace 40% of your pre-retirement paycheck if you earn an average wage. But living on 60% less income could be challenging, even at a time when your expenses might be lower. So it's important to have savings to supplement those benefits. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy ...

Core Viewpoint - Novo Nordisk has initiated legal action against U.S. telehealth company Hims & Hers, alleging patent infringement [1] Company Summary - Novo Nordisk is a Danish pharmaceutical company known for its focus on diabetes care and other chronic conditions [1] - Hims & Hers is a telehealth company based in the U.S. that provides various health services, including prescription medications [1]